Concepedia

Richa Rathore

RR

Statistics

Publications

14

Citations

415

H-Index

12

Active since

2012

Affiliations

Washington University in St. Louis(Current)

Natera (United States)

Stanford Health Care

The University of Texas MD Anderson Cancer Center

Huntsman Cancer Institute

Richa Rathore is an author at Washington University in St. Louis specializing in medicine, oncology, and metabolic reprogramming in cancer.

ORCID

Publications per year

2012–2025

14

Publications

14

Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors

Bethany C. Prudner, Richa Rathore, Anthony M. Robinson et al. · Clinical Cancer Research · 2019 · 65 citations · Full text

, , +17

Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma

Anthony M. Robinson, Richa Rathore, Nathan Redlich et al. · Cell Death and Disease · 2019 · 64 citations · Full text

, , +15

PHGDH as a mechanism for resistance in metabolically-driven cancers

Richa Rathore, Charles R. Schutt, Brian A. Van Tine · Cancer Drug Resistance · 2020 · 48 citations · Full text

, , +17

Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma

Richa Rathore, Katharine E. Caldwell, Charles R. Schutt et al. · Cell Reports · 2021 · 48 citations · Full text

, , +17

Targeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imaging

Luke Vistain, Matthew W. Rotz, Richa Rathore et al. · Chemical Communications · 2015 · 31 citations

, , +17

1–5 of 14